April 17, 2015
United States of America ex rel. et al v. Avanir Pharmaceuticals, Inc.
Case Number:
1:15-cv-01250
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 26, 2019
Avanir To Pay $108M Over Nuedexta Drug Kickback Scheme
Drugmaker Avanir Pharmaceuticals has agreed to shell out more than $108 million in criminal penalties, forfeiture and civil damages for an alleged kickback scheme that involved the company paying physicians to prescribe its drug Nuedexta, the U.S. Department of Justice announced Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login